Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence. - Wikidata - wikimedia - TriplyDB

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

http://www.wikidata.org/entity/Q38017721

about

Chagas disease in the 21st century: a public health success or an emerging threat?Mechanisms of cellular invasion by intracellular parasites In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis.Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.Trypanocidal Activity of Long Chain Diamines and Aminoalcohols.Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.Early Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes

P2860

Q24594371-3E34453C-DC1F-4296-8475-B17675BA761A Q27010243-D01B6D5A-6243-453A-84D6-226DB29F6DC2 Q27304890-62894340-AB68-43D0-8703-10E213F718D0 Q28546218-C260E5F0-CE7F-42BB-9367-684B79BCFEC9 Q35692509-F7529751-640C-43FB-A6D7-4EAD2366F324 Q37363592-45EB594D-0162-4AAB-9B77-0B023FF1A09E Q38742510-DD55F9CB-A569-4423-AA9C-3DD9898705E7 Q39168166-37D942B2-B2A1-4ED2-8730-86F4B0B20D00 Q39193707-94034501-3C6C-4B18-BA42-CC786E3B398F Q58773608-CDE910EB-646C-4967-8ABF-0643DD2590B1

P2860

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

http://www.wikidata.org/entity/Q38017721

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

@en

type

label

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

@en

prefLabel

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

@en

P1433

Q38017721-CF0CE037-DDF3-4227-91A5-78565D872F3D

P1476

Q38017721-C186CDB8-8206-4206-B8E3-6204624297E0

P2093

Q38017721-1299A2EC-9953-4CAD-AA70-17A5B6DA508D

Q38017721-BFA28185-9506-4F90-9EE2-64D87F76A272

Q38017721-EFF1D6BD-70CB-4792-9CC5-7F3C84973023

Q38017721-F92453AA-4990-4901-B625-F51085924538

Q38017721-FF0CA47B-4655-440B-A03A-636054481514

P2860

Q38017721-01F786F7-6776-43DB-896A-E3A569B0D77A

Q38017721-0C4423B7-1D8C-4167-8D54-D30D81A12AC3

Q38017721-1E208F6B-5AE7-456F-8F4C-E979F3A85FAF

Q38017721-2B5BD8B1-D10E-43D7-8315-53B18896013F

Q38017721-2FC2C924-CA4C-4DCD-9A93-3F9A66CF41D2

Q38017721-3156D8B4-DB68-4429-B3A5-52373EEBA59B

Q38017721-32E3FB73-85E7-4647-BCE8-BA314E467633

Q38017721-3CD2659D-3C6F-480C-96AE-C048FC9C8ADC

Q38017721-3E3EA824-8EBE-4494-8405-EB838126C857

Q38017721-41F28486-2A2C-4EB2-8170-231C5C6C6438

P304

Q38017721-2B61A028-E1AE-4C3D-BE61-D2F1678C3B01

P31

Q38017721-B5828953-2FDE-4544-96B1-1AA1C9A4E7F9

P356

Q38017721-FEB6E6E7-2C10-482C-83BB-FBB0EC6F0C69

P433

Q38017721-28240CB3-061E-419D-AC76-60E977188EC7

P478

Q38017721-23C920C4-3440-40AD-8E39-DE05D4FF17BE

P577

Q38017721-C2FDA978-C8B4-46AD-86EB-CE586BD2EE17

P5875

Q38017721-BF4023D4-1CCF-463A-A6BB-70065893D40C

P698

Q38017721-C8F7EF78-1CA4-4E28-9E31-0A8E8D2B5173

P921

Q38017721-ADE12E4F-27CA-42D9-B0F7-4E165CF44DE9

Q38017721-B3BF6FB2-11DF-4217-B17E-E99F98066152

P356

J.1365-3156.2012.03025.X

P1433

Tropical Medicine and International Health

P1476

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.

@en

P2093

Fredy Roberto Salazar Gutierrez

http://www.w3.org/2001/XMLSchema#string

João Santana Silva

http://www.w3.org/2001/XMLSchema#string

Manuela Sales Lima Nascimento

http://www.w3.org/2001/XMLSchema#string

Maria Adelaide Do-Valle-Matta

http://www.w3.org/2001/XMLSchema#string

Paulo Marcos Matta Guedes

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi

Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago

Adverse events after the use of benznidazole in infants and children with Chagas disease

The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-kappa B

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease

Current and developing therapeutic agents in the treatment of Chagas disease

Clinical and epidemiological aspects of Chagas disease.

P304

1057-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-3156.2012.03025.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225294817

http://www.w3.org/2001/XMLSchema#string

P698

22686518

http://www.w3.org/2001/XMLSchema#string

P921